Testing effectiveness (Phase 2)Study completedNCT03126019What this trial is testingINCB050465 in Relapsed or Refractory Follicular LymphomaWho this might be right forLymphoma Incyte Corporation 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04533581What this trial is testingStudy of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)Who this might be right forIndolent B-cell Non-Hodgkin's Lymphoma Kyowa Kirin Co., Ltd. 61
Not applicableStudy completedNCT00521430What this trial is testingDonor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Asan Medical Center 30
Not applicableUnknownNCT00429065What this trial is testingTreatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.Who this might be right forNon-Hodgkin Lymphoma Instituto Nacional de Cancerologia de Mexico 30
Not applicableNot Yet RecruitingNCT06720207What this trial is testingEfficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma LesionsWho this might be right forNon Hodgkin's LymphomaMultiple Myeloma (MM) Shanghai East Hospital 30
Early research (Phase 1)Not Yet RecruitingNCT07254793What this trial is testingProphylactic and Therapeutic DLI-X for Leukemia Relapse After HCTWho this might be right forAcute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more University of Arizona 94
Testing effectiveness (Phase 2)Study completedNCT02723071What this trial is testingOcrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's Lymphoma Hoffmann-La Roche 48
Testing effectiveness (Phase 2)WithdrawnNCT01652014What this trial is testingSingle or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01663714What this trial is testingOpen Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma.Who this might be right forLymphoma, Non-Hodgkin GlaxoSmithKline 30
Early research (Phase 1)Active Not RecruitingNCT04447716What this trial is testingAn Early Phase Study of Venetoclax, Lenalidomide, and Rituximab/Hyaluronidase in Slow-Growing Lymphomas That Have Come Back After Treatment or Have Not Responded to TreatmentWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Follicular LymphomaRecurrent Indolent Adult Non-Hodgkin Lymphoma+5 more Thomas Jefferson University 4
Early research (Phase 1)Ended earlyNCT04045028What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin LymphomaWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma Genentech, Inc. 41
Testing effectiveness (Phase 2)WithdrawnNCT03602898What this trial is testingComparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWho this might be right forAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic Leukemia+10 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01839916What this trial is testingDonor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more University of Chicago 77
Early research (Phase 1)Not Yet RecruitingNCT07335328What this trial is testingFully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell MalignanciesWho this might be right forB-cell Non Hodgkin Lymphoma Medical College of Wisconsin 24
Not applicableNot Yet RecruitingNCT03969693What this trial is testingLymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern ChemoradiationWho this might be right forMediastinal LymphomaHodgkin LymphomaNon Hodgkin Lymphoma Chang Gung Memorial Hospital 50
Early research (Phase 1)UnknownNCT00008021What this trial is testingMonoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma University of California, Davis
Early research (Phase 1)Ended earlyNCT05144334What this trial is testingBTX-1188 in Subjects With Advanced MalignanciesWho this might be right forAdvanced Solid TumorNon Hodgkin LymphomaAcute Myeloid Leukemia Biotheryx, Inc. 8
Early research (Phase 1)Looking for participantsNCT06875063What this trial is testingGB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHLWho this might be right forNon-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell The First Affiliated Hospital of Xiamen University 45
Testing effectiveness (Phase 2)Study completedNCT00021372What this trial is testingPaclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Fox Chase Cancer Center 25
Not applicableLooking for participantsNCT05921812What this trial is testingBiochemical Role of Circulating microRNAs Expression as Diagnostic Markers for Non-Hodgkin's Lymphoma PatientsWho this might be right forNon-Hodgkin Lymphoma Sohag University 70